UniProtKB/Swiss-Prot O43707: Variant p.Cys793Tyr

Alpha-actinin-4
Gene: ACTN4
Feedback?

Variant information Variant position:

793 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Cysteine (C) to Tyrosine (Y) at position 793 (C793Y, p.Cys793Tyr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (C) to large size and aromatic (Y) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

Found in patients with IgA nephropathy; uncertain significance. Any additional useful information about the variant.

Sequence information Variant position:

793 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

911 The length of the canonical sequence.
Location on the sequence:

SFNHFDKDHGGALGPEEFKA C LISLGYDVENDRQGEAEFNR The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SFNHFDKDHGGALGPEEFKACLISLGYDVENDRQGEAEFNR

Mouse                         SFNHFDKDHGGALGPEEFKACLISLGYDVENDRQGDAEFNR

Rat                           SFNHFDKDHGGALGPEEFKACLISLGYDVENDRQGDAEFNR

Bovine                        SFNHFDKDHGGALGPEEFKACLISLGYDVENDRQGDAEFNR

Chicken                       SFNHFDKDHCGALGPEEFKACLISLGYDVENDRQGDAEFNR

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 911	Alpha-actinin-4
Domain	765 – 800	EF-hand 1
Region	736 – 911	Mediates interaction with MICALL2
Binding site	778 – 778
Binding site	780 – 780
Binding site	789 – 789
Modified residue	779 – 779	N6-acetyllysine

Literature citations
Mutational analysis of ACTN4, encoding alpha-actinin 4, in patients with focal segmental glomerulosclerosis using HRM method.
Safarikova M.; Reiterova J.; Safrankova H.; Stekrova J.; Zidkova A.; Obeidova L.; Kohoutova M.; Tesar V.;
Folia Biol. (Praha) 59:110-115(2013)
Cited for: VARIANTS FSGS1 THR-427 AND ASP-748; VARIANTS VAL-784; ARG-786; LEU-787; SER-787; TYR-793; ASP-798 AND MET-801;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.